Neil M Iyengar
Overview
Explore the profile of Neil M Iyengar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
2066
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adams S, Rivera-Theurel F, Scott J, Nadler M, Foulkes S, Leong D, et al.
Eur Heart J
. 2025 Mar;
PMID: 40036781
The aim of this whitepaper is to review the current state of the literature on the effects of cardio-oncology rehabilitation and exercise (CORE) programmes and provide a roadmap for improving...
2.
Goncalves M, Iyengar N
Cell Metab
. 2025 Feb;
37(2):305-306.
PMID: 39908983
Triple-negative breast cancer (TNBC) is highly glycolytic and lacks effective biomarkers for therapy response. The BREAKFAST trial showed that a fasting-mimicking diet (FMD) improved pathological complete response (pCR) rates to...
3.
Iyengar N, Scott J, Lee J, Lavery J, Foug K, Lee C, et al.
Cancer
. 2024 Sep;
131(1):e35575.
PMID: 39306704
Background: Whether structured exercise therapy improves chemotherapy delivery, tolerability, and tumor response is unclear. Methods: This was a secondary analysis of a phase 2 trial investigating exercise therapy (n = ...
4.
Shen S, Salehi E, White C, Chen Y, Iyengar N
NPJ Breast Cancer
. 2024 Jul;
10(1):53.
PMID: 38951532
Post-diagnosis weight gain is common in early-stage breast cancer and is associated with increased risk of recurrence and mortality. Intentional weight loss is difficult to maintain, and digital lifestyle interventions...
5.
Soldato D, Michiels S, Havas J, Di Meglio A, Pagliuca M, Franzoi M, et al.
J Clin Oncol
. 2024 Jun;
42(25):3022-3032.
PMID: 38838281
Purpose: Postdiagnosis exercise is associated with lower breast cancer (BC) mortality but its link with risk of recurrence is less clear. We investigated the impact and dose-response relationship of exercise...
6.
Elliott M, Shen S, Lam D, Brown T, Lawson M, Iyengar N, et al.
Am Soc Clin Oncol Educ Book
. 2024 May;
44(3):e432564.
PMID: 38815189
Addressing the challenges of survivorship necessitates a comprehensive, patient-centered approach, focusing on mitigating risk through lifestyle modification, identifying distant recurrence, and optimization of breast imaging. This article will discuss the...
7.
Iyengar N, Williams C, Rogan M, Campbel L, Mertz S, Block J, et al.
Future Oncol
. 2024 Apr;
20(26):1879-1891.
PMID: 38682677
Patients with metastatic breast cancer (MBC) may be vulnerable to changes in healthcare management, safety standards and protocols that occurred during the COVID-19 pandemic. The REthink Access to Care &...
8.
Ben-Chetrit N, Niu X, Sotelo J, Swett A, Rajasekhar V, Jiao M, et al.
bioRxiv
. 2023 Nov;
PMID: 37961223
Tumor-infiltrating macrophages support critical steps in tumor progression, and their accumulation in the tumor microenvironment (TME) is associated with adverse outcomes and therapeutic resistance across human cancers. In the TME,...
9.
Shen S, Chen Y, Carpio A, Chang C, Iyengar N
Cancer
. 2023 Sep;
129(24):3854-3861.
PMID: 37743730
Purpose: The combination of fulvestrant with alpelisib, a PI3K inhibitor, improves progression-free survival in metastatic hormone receptor-positive, PIK3CA-mutant breast cancer. This study describes the incidence, risk factors, and treatment of...
10.
Hovsepyan G, Barac A, Brasky T, Shadyab A, Lehman A, McLaughlin E, et al.
Cancer Med
. 2023 Jun;
12(15):16626-16636.
PMID: 37381978
Background: Published studies have demonstrated inconclusive relationships between serum lipid levels and mortality after cancer. Methods: The primary objective was to evaluate the relationship between fasting lipid levels and mortality...